Publication:
Eotaxin-2 and eotaxin-3 in malaria exposure and pregnancy.

dc.contributor.authorMancebo-Perez, Cristina
dc.contributor.authorVidal, Marta
dc.contributor.authorAguilar, Ruth
dc.contributor.authorBarrios, Diana
dc.contributor.authorBardaji, Azucena
dc.contributor.authorOme-Kaius, Maria
dc.contributor.authorMenendez, Clara
dc.contributor.authorRogerson, Stephen J
dc.contributor.authorDobaño, Carlota
dc.contributor.authorMoncunill, Gemma
dc.contributor.authorRequena, Pilar
dc.contributor.funderEuropean Union Seventh Framework Pro-gramme
dc.contributor.funderMalaria in Pregnancy Consortium (MiPc) through a grant from the Bill & Melinda Gates Foundation
dc.contributor.funderEuropean Union FP7 Network of Excellence
dc.contributor.funderGovernment of Spain, Ramon y Cajal Fellowship
dc.contributor.funderSpanish Ministry of Science and Innovation and State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program
dc.contributor.funderGeneralitat de Catalunya through the CERCA Program
dc.date.accessioned2023-05-03T13:34:16Z
dc.date.available2023-05-03T13:34:16Z
dc.date.issued2022-11-07
dc.description.abstractEotaxin-1 concentrations in plasma have been inversely associated with malaria exposure, malaria infection and pregnancy, but the effect of these conditions on the levels of the related chemokines eotaxin-2 and eotaxin-3 remains unknown. Eotaxin-2 and -3 concentrations were measured in 310 peripheral or placental plasma samples from pregnant and non-pregnant individuals from Papua New Guinea (malaria-endemic country) and Spain (malaria-naïve individuals) with previous data on eotaxin-1 concentrations. Correlations between eotaxin concentrations were examined with the Spearman's test. Differences in eotaxin concentrations among groups were evaluated with the Kruskal-Wallis or Mann Whitney tests. The pairwise Wilcoxon test was performed to compare eotaxin-2 concentration between peripheral and placental matched plasmas. Univariable and multivariable linear regression models were estimated to assess the association between eotaxins and Plasmodium infection or gestational age. Eotaxin-2 concentrations in plasma showed a weak positive correlation with eotaxin-3 (rho = 0.35, p  Although a clear epidemiological negative association is observed between eotaxins concentrations and malaria exposure and/or infection, pregnancy may alter this association for eotaxin-2. Further research is required to understand the role of these chemokines in this disease and in combination with pregnancy.
dc.description.versionSi
dc.identifier.citationMancebo-Pérez C, Vidal M, Aguilar R, Barrios D, Bardají A, Ome-Kaius M, et al. Eotaxin-2 and eotaxin-3 in malaria exposure and pregnancy. Malar J. 2022 Nov 15;21(1):336.
dc.identifier.doi10.1186/s12936-022-04372-7
dc.identifier.essn1475-2875
dc.identifier.pmcPMC9667598
dc.identifier.pmid36380370
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667598/pdf
dc.identifier.unpaywallURLhttps://malariajournal.biomedcentral.com/counter/pdf/10.1186/s12936-022-04372-7
dc.identifier.urihttp://hdl.handle.net/10668/20321
dc.issue.number1
dc.journal.titleMalaria journal
dc.journal.titleabbreviationMalar J
dc.language.isoen
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number11
dc.provenanceRealizada la curación de contenido 14/08/2024
dc.publisherBioMed Central Ltd.
dc.pubmedtypeJournal Article
dc.relation.projectIDFP7/2007–2013
dc.relation.projectIDPREGVAX FP7-EALTH-201588
dc.relation.projectID46099
dc.relation.projectIDRYC-2013–14512
dc.relation.projectIDCEX2018-000806-S
dc.relation.publisherversionhttps://malariajournal.biomedcentral.com/articles/10.1186/s12936-022-04372-7
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectChemokine
dc.subjectEotaxin
dc.subjectMalaria
dc.subjectPlacenta
dc.subjectPregnancy
dc.subject.decsComplicaciones infecciosas del embarazo
dc.subject.decsComplicaciones parasitarias del embarazo
dc.subject.decsEmbarazo
dc.subject.decsFemenino
dc.subject.decsHumanos
dc.subject.decsInmunoglobulina G
dc.subject.decsMalaria
dc.subject.decsMalaria falciparum
dc.subject.decsPlacenta
dc.subject.decsPlasmodium falciparum
dc.subject.decsQuimiocina CCL11
dc.subject.decsQuimiocina CCL24
dc.subject.decsQuimiocina CCL26
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshPregnancy
dc.subject.meshChemokine CCL11
dc.subject.meshChemokine CCL24
dc.subject.meshChemokine CCL26
dc.subject.meshImmunoglobulin G
dc.subject.meshMalaria
dc.subject.meshMalaria, Falciparum
dc.subject.meshPlacenta
dc.subject.meshPlasmodium falciparum
dc.subject.meshPregnancy Complications, Infectious
dc.subject.meshPregnancy Complications, Parasitic
dc.titleEotaxin-2 and eotaxin-3 in malaria exposure and pregnancy.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number21
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9667598.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format